Ben Kopp MD/MPH
            
            @kidslungdoc.bsky.social
          
          190 followers
          120 following
          32 posts
        
          Physician scientist at Emory/ Children’s Healthcare of Atlanta.  Co-Director of CF-AIR and Director Pulmonary Sickle Cell Program. Christian, champion for children and environmental health
      
        Posts
        Media
        Videos
        Starter Packs
      
    
        
      Reposted by Ben Kopp MD/MPH
    
  
  
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Aug 27
        
        
      
    
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Aug 27
        
        
      
    
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · May 15
        
        
        
            Altered nasal and oral microbiomes define pediatric sickle cell disease - PubMed
            The oral and nasal cavities are susceptible to environmental exposures including pathogenic microbes. In individuals with systemic disorders, antibiotic exposure, changes to the immune system, or chan...
          
            
            pubmed.ncbi.nlm.nih.gov
          
        
      
    
        
      Reposted by Ben Kopp MD/MPH
    
  
          
              Alondra Nelson
              @alondra.bsky.social
          
              · Feb 8
        
        
          
      Excellent 🧵 on this evening's NIH announcement of a dramatic reduction in indirect rates for research institutions, which amounts to a generational restructuring of the US research and development ecosystem. These cuts are effective immediately, not just for new grants but for existing ones.
    
        
      6. The policy does not just affect funding going forward. All existing NIH grants will have their indirect rates cut to 15% as of today, the date of issuance. 
For a large university, this creates a sudden and catastrophic shortfall of hundreds of millions of dollars against already budgeted funds.
  For a large university, this creates a sudden and catastrophic shortfall of hundreds of millions of dollars against already budgeted funds.
        
      Reposted by Ben Kopp MD/MPH
    
  
        
      Reposted by Ben Kopp MD/MPH
    
  
  
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Dec 20
        
        
        
            Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series - PubMed
            Following the approval of elexacaftor/tezacaftor/ivacaftor (ETI), there have been post-marketing reports and published cases of papilledema and intracranial hypertension in children with cystic fibros...
          
            
            pubmed.ncbi.nlm.nih.gov
          
        
      
    
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Dec 16
        
        
      
    
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Dec 14
        
        
      
    
          
              Ben Kopp MD/MPH
              @kidslungdoc.bsky.social
          
              · Dec 11
        
        
        
            Glycemia and Insulin Secretion in Cystic Fibrosis Two Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO - PubMed
            After two years of ETI, fasting glucose and HbA1c showed modest decreases. Glucose tolerance varied, and overall measures of insulin secretion did not deteriorate.
          
            
            pubmed.ncbi.nlm.nih.gov
          
        
      
     
        